Claventin and bilirubin conjugated increased Patient Reports February 13, 2012

Claventin Side Effects Report #5946525-9
Claventin side effect was reported by a Consumer or non-health professional from FRANCE on Oct 30, 2008. Male patient, 47 years of age, was treated with Claventin. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, hepatocellular injury. Claventin dosage: unknown. During the same period patient was treated with TRIFLUCAN, ZYVOXID, TIENAM, AMOXICILLIN AND CLAVULANATE POTASSIUM, ARIXTRA, DAFALGAN. Patient was hospitalized. Patient recovered.